A final decision on the updated application is expected in the first half of 2026, while intravenous (IV) Saphnelo remains commercially available
The program seeks to boost regulatory predictability, support construction of US-based manufacturing sites
This achievement validates global demand and catapults Wanbury into high-growth acceleration
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
Excluding Vacaville-related business, organic CER sales growth reached the low-teens with improved CORE EBITDA margins, in line with Lonza’s CDMO Organic Growth Model
In the SHORE phase 3 study, amlitelimab, used in combination with topical therapies, met all primary and key secondary endpoints at Week 24
The new functionality complements Parse’s existing Evercode immune products
TruVerus is the only FDA cleared, multi-modal platform capable of delivering comprehensive routine testing from a single lithium heparin sample
Subscribe To Our Newsletter & Stay Updated
